Growing Pipeline
ABVC currently has six drugs and three medical devices in development.
ABVC’s relationships around the world with the most prestigious medical research institutions are a significant asset that the company builds on every day.
The company begins the process of developing its pipeline by carefully tracking new medical discoveries or medical device technologies in research institutions around the world. Pre-clinical, disease animal model and Phase I safety studies are examined closely by ABVC’s scientists and other specialists known to the company to identify the most promising new drugs.
Once a drug is shown to be a good candidate for translational development, ABVC begins to introduce the proprietary clinical plan to highly-respected principal investigators in the United States, Australia and Taiwan. In almost all cases, research institutions in each of those countries are eager to work with the company to move forward with Phase II clinical trials.
Product Development Pipeline
